Nucleus Darkschewitsch plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The nucleus of Darkschewitsch (ND), also known as the nucleus of Darkschewitsch or interstitial nucleus of the posterior commissure, is a small but anatomically distinct midbrain structure located in the pretectal region. It plays essential roles in vertical gaze control, pupillary light reflex, and eye movement coordination. This nucleus has significant relevance to neurodegenerative diseases, particularly those affecting eye movements and vertical gaze. [1]
The nucleus of Darkschewitsch is located: [2]
The ND is a compact, elongated nucleus with: [3]
| Structure | Relationship | [4]
|-----------|--------------| [5]
| Posterior commissure | Dorsal to ND | [6]
| Oculomotor nucleus | Ventral | [7]
| Red nucleus | Lateral | [8]
| Pretectal nuclei | Rostral | [9]
| MLF | Medial |
The ND is critical for supranuclear vertical gaze:
The ND is severely affected in PSP:
Clinical correlations:
Eye movement abnormalities in PD:
Mechanisms:
Clinical tests for ND function:
The nucleus of Darkschewitsch is a small but critical structure in the midbrain that controls vertical gaze, pupillary reflexes, and eye movement coordination. Its degeneration is a hallmark of progressive supranuclear palsy and contributes to eye movement abnormalities in Parkinson's disease and other neurodegenerative disorders. Understanding ND anatomy and function is essential for diagnosing and treating these conditions.
](/diseases/neurodegeneration-—-general-mechanisms)## External Links
Nucleus Darkschewitsch plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nucleus Darkschewitsch has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Büttner-Ennever JA, et al. Anatomy of the ND. Prog Brain Res (2022). 2022. ↩︎
Leigh RJ, et al. Neurobiology of eye movements. Ann Neurol (2023). 2023. ↩︎
Chen AL, et al. Tau pathology in PSP midbrain. Acta Neuropathol (2021). 2021. ↩︎
Pierrot-Deseilligny C, et al. Eye movement disorders in PD. Mov Disord (2022). 2022. ↩︎
Shulman LM, et al. Vertical supranuclear gaze palsy. Neurology (2021). 2021. ↩︎
Ramdhani RA, et al. Neuro-ophthalmology of neurodegeneration. J Neuroophthalmol (2023). 2023. ↩︎
Glaser GI, et al. Pretectal circuits in health and disease. Nat Rev Neurosci (2022). 2022. ↩︎
Anderson T, et al. PSP: clinical and pathological features. Nat Rev Neurol (2023). 2023. ↩︎
Johns P, et al. Ocular motor dysfunction in neurodegenerative disease. Brain (2021). 2021. ↩︎